The Editorial on the Research Topic
Obesity is a major public health problem that constitutes a worldwide epidemic, often associated with metabolic and cardiovascular diseases, and some types of cancers (1). The rising prevalence of obesity and obesity-related medical conditions has therefore promoted much interest and research on the role of adipose tissue, previously seen simply as an inert lipid storage site. In the last two decades, many biologically active molecules produced by fat have been identified, evoking a role of this tissue in previously unsuspected processes, including inflammation, insulin, and glucose homeostasis, angiogenesis, and hemostasis (2). Hormonal factors produced by adipose cells have been collectively called “adipokines”, and include about a hundred of known molecules, such as leptin, adiponectin, resistin, apelin, visfatin, VEGF, PAI-1, and many other, not yet identified factors, that have recently emerged by proteomic strategies (3, 4). It has been postulated that the adipose tissue of the obese, becoming dysfunctional by changes in the secretion pattern of adipokines, may sustain inflammation, insulin resistance, and a pro-thrombotic state with endothelial dysfunction, all conditions underpinning obesity-related comorbidities (5, 6). The notion of obesity as a systemic, low-grade inflammatory state promoting insulin resistance has become commonly accepted (7), although the event(s) and the related molecular mechanisms that initially trigger adipose tissue dysfunction have remained still poorly characterized. In this regard, a direct role of hypoxia in adipose and non-adipose cells in fat tissue has been demonstrated both in vivo, in animal models, and in in vitro studies (8–11). Oxidative stress, endoplasmic reticulum stress, and the activation of the unfolded protein response can represent additional cellular processes, indirectly linked to hypoxia, which may operate in hypertrophic fat cells.
The aim of this research topic was to provide insights into the mechanisms triggered by hypoxia in obesity.
Hypoxia-inducible factor 1 (HIF-1) is considered the main nuclear transcription factor that mediates cellular response to low oxygen tension (12). Although the scenario is far from be complete, many HIF-1-inducible genes have been identified in the adipose tissue, including leptin, VEGF, GLUT1, metalloproteinases MMP2 and MMP9, IL-4, IL-6, and PAI-1, thereby implicating a role of hypoxia in important processes, such as inflammation, insulin resistance and glucose intolerance, and angiogenesis (9, 13, 14). In this context, the molecular interplay between HIF-1 and other nuclear partners involved in the gene networks affected by oxygen availability (i.e., NF-κB, HIF-2, CREB, PPARγ) deserves further investigation.
Messineo et al. contributed a research article on the physical and functional interaction between HIF-1 and HMGA1, two factors that share important roles in adipose tissue and inflammation. Using in vitro differentiated 3T3-L1 adipocytes, cooperation between HIF-1 and HMGA1 proteins was demonstrated for the first time in the transcriptional activation of the hypoxia-responsive Vegf and visfatin genes, suggesting that HMGA1 may represent a novel nuclear partner of HIF-1, thereby serving as a modulator of HIF-1 activity in hypoxia. A more detailed analysis of the molecular cross-talk between these two factors may help identifying protein and gene networks relevant to obesity.
A plethora of studies using transgenic models have addressed the role of the HIFs on adipose dysfunction (15–18). Although findings are complex to interpret and sometimes contradictory, evidences exist that the HIF pathway does contribute to the obese phenotypes.
Lin and Yun reviewed the role of HIF-2 in hypertrophic cardiomyopathy, a condition that may occur in obesity independently of other cardiovascular risk factors, including hypertension, diabetes, and coronary heart disease. The Authors drew attention to the fact that stabilization of HIF-2, as obtained in genetically engineered mice, is followed by fat inflammation and lethal cardiomegaly, pointing to a novel pathophysiological role of HIF-2 in driving NF-κB and NFAT activation, that may ultimately compromise heart development, morphology, and function.
Goossens and Blaak focused into the controversial relevance of oxygen in human obesity and delineated future directions. Starting from the consolidated notion that adipose tissue hypoxia plays an important role in adipose dysfunction in mouse models of obesity, the Authors summarized current findings in human obesity, underlining how methodological differences may account for discrepant results (i.e., measurements of adipose tissue oxygen partial pressure and metabolic markers). Accordingly, advancements are expected from studies in progress with obese patients before and after weight loss and from techniques that allow for a better characterization of the degree, severity, and pattern of hypoxia.
Heinonen et al. reviewed the effects of hypoxia and the consequent physiological adaptation to altitude exposure and physical exercise, in terms of cardiovascular and metabolic responses. While focusing on conditions implicating hypoxia in adipose tissue during rest and moderate or intense exercise, the Authors discussed the mechanisms that influence adipose tissue blood flow in each condition and considered the positive and negative consequences of hypoxia and hyperoxia in relation to treatment of obesity.
The effects of hypoxia on the different adipose tissue depots (white, brown, and brite) were discussed in a paper by Trayhurn and Alomar, where Authors focused also on the less explored brown adipose tissue, in which reduced oxygen tension in obese mice leads to whitening of brown fat and mitochondrial loss and dysfunction. They hypothesized that, as in white adipose tissue, oxygen deprivation in brown fat may trigger changes in adipokine secretion, increase glucose uptake and lactate release, reduce free fatty acid uptake, and promote fibrosis and insulin resistance, thus contributing to the development of the metabolic syndrome. In an emerging complex scenario, as a consequence of obesity and hypoxia, the production of lactate by anaerobic metabolism in the white adipose tissue (19), through the stimulation of UCP1, promotes thermogenesis via lipid oxidation and the development of brite cells within white depots, leading to browning of white fat.
In summary, these articles have contributed importantly to the current debate linking hypoxia to obesity. Our hope is that a better understanding of the role of hypoxia in adipose tissue will contribute to deepen our knowledge on the pathophysiology of obesity and obesity-related disorders, leading to innovative targets for preventive and therapeutic interventions.
Statements
Author contributions
All authors listed have made substantial, direct, and intellectual contribution to the work and approved it for publication.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
KopelmanPG. Obesity as a medical problem. Nature (2000) 404:635–43.10.1038/35007508
2
WakiHTontonozP. Endocrine functions of adipose tissue. Annu Rev Pathol (2007) 2:31–56.10.1146/annurev.pathol.2.010506.091859
3
FasshauerMBlüherM. Adipokines in health and disease. Trends Pharmacol Sci (2015) 36:461–70.10.1016/j.tips.2015.04.014
4
RenesJMarimanE. Application of proteomics technology in adipocyte biology. Mol Biosyst (2013) 9:1076–91.10.1039/c3mb25596d
5
LumengCNSaltielAR. Inflammatory links between obesity and metabolic disease. J Clin Invest (2011) 121:2111–7.10.1172/JCI57132
6
KahnBBFlierJS. Obesity and insulin resistance. J Clin Invest (2000) 106:473–81.10.1172/JCI10842
7
SaltielAROlefskyJM. Inflammatory mechanisms linking obesity and the metabolic disease. J Clin Invest (2017) 127:1–4.10.1172/JCI92035
8
HosogaiNFukuharaAOshimaKMiyataYTanakaSSegawaKet alAdipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes (2007) 56:901–11.10.2337/db06-0911
9
KabonBNageleAReddyDEagonCFleshmanJWSesslerDIet alObesity decreases perioperative tissue oxygenation. Anesthesiology (2004) 100:274–80.
10
TrayhurnP. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev (2013) 93:1–21.10.1152/physrev.00017.2012
11
FujisakaSUsuiIIkutaniMAminuddinATakikawaATsuneyamaKet alAdipose tissue hypoxia induces inflammatory M1 polarity of macrophages in an HIF-1a-dependent and HIF-1a-independent manner in obese mice. Diabetologia (2013) 56:1403–12.10.1007/s00125-013-2885-1
12
WangGLJiangBHRueEASemenzaGL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A (1995) 92:5510–4.
13
EltzschigHKCarmelietP. Hypoxia and inflammation. N Engl J Med (2011) 364:656–65.10.1056/NEJMra0910283
14
BlüherM. Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes (2009) 17:241–50.10.1055/s-0029-1192044
15
HalbergNKhanTTrujilloMEWernstedt-AsterholmIAttieADSherwaniSet alHypoxia-inducible factor 1 alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol (2009) 29:4467–83.10.1128/MCB.00192-09
16
JiangCQuAMatsubaraTChanturiyaTJouWGravilovaOet alDisruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice. Diabetes (2011) 60:2484–95.10.2337/db11-0174
17
LeeKYGestaSBoucherJWangXLKahnCR. The differential role of Hif1β/Arnt and the hypoxic response in adipose function, fibrosis, and inflammation. Cell Metab (2011) 14:491–503.10.1016/j.cmet.2011.08.006
18
ZhangXLLamKSYeHChungSKZhouMWangYet alAdipose tissue-specific inhibition of hypoxia-inducible factor-1α induces obesity and glucose intolerance by impeding energy expenditure in mice. J Biol Chem (2010) 285:32869–77.10.1074/jbc.M110.135509
19
CarrièreAJeansonYBerger-MüllerSAndréMChenouardVArnaudEet alBrowning of white adipose cells by intermediate metabolites: an adaptive mechanism to alleviate redox pressure. Diabetes (2014) 63:3253–65.10.2337/db13-1885
Summary
Keywords
hypoxia, HIF-1, HIF-2, obesity, adipose tissue
Citation
Foti DP and Brunetti A (2017) Editorial: “Linking Hypoxia to Obesity”. Front. Endocrinol. 8:34. doi: 10.3389/fendo.2017.00034
Received
12 December 2016
Accepted
08 February 2017
Published
22 February 2017
Volume
8 - 2017
Edited by
Robert Kenneth Semple, University of Cambridge, UK
Reviewed by
Robert Kenneth Semple, University of Cambridge, UK; Zoi Michailidou, University of Edinburgh, UK
Updates
Copyright
© 2017 Foti and Brunetti.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Daniela P. Foti, foti@unicz.it; Antonio Brunetti, brunetti@unicz.it
Specialty section: This article was submitted to Genomic Endocrinology, a section of the journal Frontiers in Endocrinology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.